2015•Autoimmunity ReviewsRequires access

Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

Sara De Carolis, Angela Botta, Silvia Salvi, E. di Pasquo, Gelsomina Del Sordo, Cristina Garufi, Antonio Lanzone, Maria Pia De Carolis

Open publisher page 43 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 43 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Hydroxychloroquine, Antiphospholipid syndrome, Medicine, Refractory (planetary science), Regimen, Pregnancy, Internal medicine, Antibody

Back to paper search Browse research topics Original source

Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? — Research Paper | ScholarLens